The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC).
 
Ulrich-Frank Pape
Honoraria - Ipsen; Novartis
Research Funding - Ipsen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Stefan Kasper
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Roche; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Merck; Roche
 
Johannes Meiler
Honoraria - Amgen; Novartis; Roche; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Novartis; Roche; Sanofi/Aventis
 
Marianne Sinn
Honoraria - Amgen; Leo Pharma; Sanofi
Consulting or Advisory Role - AstraZeneca; Sanofi
Research Funding - AstraZeneca; Boston Biomedical; Incyte; Leo Pharma; Merck Sharp & Dohme; SERVIER; Taiho Pharmaceutical
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Lothar Mueller
No Relationships to Disclose
 
Oswald Burkhard
No Relationships to Disclose
 
Karel Caca
No Relationships to Disclose
 
Steffen Heeg
No Relationships to Disclose
 
Victor Rodriguez Laval
No Relationships to Disclose
 
Anya A Kühl
No Relationships to Disclose
 
Ruza Arsenic
No Relationships to Disclose
 
Holger Jansen
Consulting or Advisory Role - CellAct Pharma
 
Nalan Utku
Employment - CellAct Pharma
Leadership - CellAct Pharma
Stock and Other Ownership Interests - CellAct Pharma
Honoraria - CellAct Pharma; Mundipharma
Consulting or Advisory Role - Boehringer Ingelheim; CellAct Pharma; Mundipharma
Speakers' Bureau - Boehringer Ingelheim
Research Funding - CellAct Pharma
Patents, Royalties, Other Intellectual Property - CellAct Pharma; Harvard Medical School
Travel, Accommodations, Expenses - Boehringer Ingelheim; CellAct Pharma; Mundipharma